Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,462 across all filing types
Latest filing 2024-08-30 Director's Dealing
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 1% confidence The document is a formal notification regarding transactions in Coloplast A/S shares by a member of the executive management (Allan Bjørn Rasmussen). It explicitly references the Market Abuse Regulation (Markedsmisbrugsforordningen) Article 19, which mandates the disclosure of director and executive dealings. The document provides detailed tables of share options exercised and subsequent share sales, including dates, prices, and volumes. This fits the definition of a 'Director's Dealing' report.
2024-08-30 English
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
Director's Dealing Classification · 1% confidence The document is a short announcement titled 'Trading in Coloplast shares by board members, executives or associated persons' which directs the reader to an attached PDF for the actual transaction details. This fits the definition of a Director's Dealing (DIRS) notification, as it pertains to insider trading disclosures, and follows the 'Menu vs Meal' rule by acting as the announcement of the transaction report.
2024-08-30 Danish
Interim / Quarterly Report 2023
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive financial report for Coloplast covering the first half (H1) of the 2023/24 fiscal year. It includes detailed financial statements, management commentary on business performance, segment analysis, and key financial metrics (EBIT, revenue, cash flow). It is not a mere announcement or certification, but the substantive interim report itself, fitting the definition of an Interim/Quarterly Report (IR). H1 2023
2024-05-07 Danish
Interim / Quarterly Report 2024
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive interim financial report for Coloplast covering the H1 2023/24 period. It includes detailed financial statements, income statement data, balance sheet information, cash flow analysis, and management commentary on strategic priorities. It is not a short announcement (it is over 100,000 characters) and contains substantive financial data, thus qualifying as an Interim/Quarterly Report (IR) rather than an Earnings Release (ER) or Report Publication Announcement (RPA). H1 2024
2024-05-07 English
Coloplast A/S - Announcement no. 02/2024 - Interim Financial Report, H1 2023/24
Earnings Release Classification · 1% confidence The document is a 'Regnskabsmeddelelse' (Financial Statement/Earnings Release) for Coloplast A/S covering the first half (H1) of the 2023/24 fiscal year. It contains key financial highlights, including organic growth, EBIT, and revenue figures, as well as management commentary and future outlook. While it mentions an attached file, the text itself provides substantive financial data and analysis, qualifying it as an Earnings Release (ER) rather than a mere announcement of a report. H1 2024
2024-05-07 Danish
Coloplast A/S - Announcement no. 02/2024 - Interim Financial Report, H1 2023/24
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Financial Report, H1 2023/24' and provides detailed financial results, including revenue, organic growth, EBIT margins, and guidance for the fiscal year. While it mentions an attachment at the end, the text itself contains substantive financial data and analysis, distinguishing it from a mere announcement of a report. Therefore, it is classified as an Interim/Quarterly Report. H1 2024
2024-05-07 Danish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.